nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Childhood medulloblastoma
|
Massimino, Maura |
|
2016 |
105 |
C |
p. 35-51 17 p. |
artikel |
2 |
Clinical significance of immunohistochemically detected extracellular matrix proteins and their spatial distribution in primary cancer
|
Čunderlíková, B. |
|
2016 |
105 |
C |
p. 127-144 18 p. |
artikel |
3 |
Editorial Board
|
|
|
2016 |
105 |
C |
p. IFC- 1 p. |
artikel |
4 |
Hepatocellular carcinoma: Exploring the impact of ethnicity on molecular biology
|
Lamarca, Angela |
|
2016 |
105 |
C |
p. 65-72 8 p. |
artikel |
5 |
Immunotherapy advances in uro-genital malignancies
|
Ratta, Raffaele |
|
2016 |
105 |
C |
p. 52-64 13 p. |
artikel |
6 |
Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning
|
Gadducci, Angiolo |
|
2016 |
105 |
C |
p. 73-83 11 p. |
artikel |
7 |
Oxaliplatin-based chemotherapy combined with traditional medicines for neutropenia in colorectal cancer: A meta-analysis of the contributions of specific plants
|
Chen, Menghua |
|
2016 |
105 |
C |
p. 18-34 17 p. |
artikel |
8 |
Primary focal prostate radiotherapy: Do all patients really need whole-prostate irradiation?
|
Jereczek-Fossa, Barbara Alicja |
|
2016 |
105 |
C |
p. 100-111 12 p. |
artikel |
9 |
Response rate to the treatment of Waldenström macroglobulinemia: A meta-analysis of the results of clinical trials
|
Santos-Lozano, A. |
|
2016 |
105 |
C |
p. 118-126 9 p. |
artikel |
10 |
Review of hematological indices of cancer patients receiving combined chemotherapy & radiotherapy or receiving radiotherapy alone
|
Shahid, Saman |
|
2016 |
105 |
C |
p. 145-155 11 p. |
artikel |
11 |
Revisiting IL-6 antagonism in multiple myeloma
|
Matthes, Thomas |
|
2016 |
105 |
C |
p. 1-4 4 p. |
artikel |
12 |
Safety of anticoagulation in the treatment of venous thromboembolism in patients with haematological malignancies and thrombocytopenia: Report of 5 cases and literature review
|
Lim, Ming Sheng |
|
2016 |
105 |
C |
p. 92-99 8 p. |
artikel |
13 |
Second line therapies in polycythemia vera: What is the optimal strategy after hydroxyurea failure?
|
Nazha, Aziz |
|
2016 |
105 |
C |
p. 112-117 6 p. |
artikel |
14 |
The evidence of toxic wastes dumping in Campania, Italy
|
Marfe, Gabriella |
|
2016 |
105 |
C |
p. 84-91 8 p. |
artikel |
15 |
Zevalin® (ibritumomab tiuxetan): After more than a decade of treatment experience, what have we learned?
|
Rizzieri, David |
|
2016 |
105 |
C |
p. 5-17 13 p. |
artikel |